Image

Prevent CardioKids

Prevent CardioKids

Recruiting
6-18 years
All
Phase N/A

Powered by AI

Overview

The aim of Prevent CardioKids is to evaluate to what extend disturbed vascular function markers are already present in children of different weight categories and whether these are age dependent. Also differences - and relationships - between vascular function measurements and plasma biomarkers between lean and overweight/obese children will be compared.

Description

The aim of Prevent CardioKids is to evaluate to what extend disturbed vascular function markers are already present in children of different weight categories and whether these are age dependent. Also differences - and relationships - between vascular function measurements and plasma biomarkers between lean and overweight/obese children will be compared.The primary endpoint is to examine the difference in micro- and macro-vasculature characteristics in children with different weight classifications (lean; overweight; obese; extreme obese; morbid obese). Secondary endpoints are differences in lipoprotein profiles, pro-inflammatory and oral glucose tolerance profiles between different age groups, between lean and overweight/obese children and in relation with the measured micro- and macro-vasculature characteristics

Eligibility

Inclusion Criteria:

  • Participation in the COACH program
  • Aged between 6 and 18 years (at time of inclusion)
  • Overweight or obesity according to IOTF criteria
        In order to be eligible to participate in the control group, a subject must meet all of the
        following criteria:
          -  Aged between 6 and 18 years
          -  Normal weight according to the IOTF criteria
          -  Undergo surgery for elective reasons
        Exclusion Criteria:
          -  Retarded children
          -  Children suffering from:
               -  Inflammatory diseases: auto-immune diseases, inflammatory bowel diseases,
                  hepatitis, dermatitis, nephritis, pancreatitis, gastro-enteritis, vasculitis,
                  salpingitis, arthritis, osteomyelitis, myositis, ear-nose-throat infections
               -  Allergic diseases: asthma, eczema, hay fever, food allergies
               -  Oncologic diseases
               -  Cystic fibrosis
               -  Type 1 diabetes mellitus
               -  Congenital metabolic diseases
          -  Malnourished children

Study details
    Cardiovascular Disease

NCT02113644

Maastricht University Medical Center

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.